|
1.
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
2.
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
3.
|
Roder DM: The epidemiology of gastric
cancer. Gastric Cancer. 5(Suppl 1): 5–11. 2002. View Article : Google Scholar
|
|
4.
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.
|
|
5.
|
Krejs GJ: Gastric cancer: epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
7.
|
Uemura N, Okamoto S, Yamamoto S, et al:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar
|
|
8.
|
Liu C and Russell RM: Nutrition and
gastric cancer risk: an update. Nutr Rev. 66:237–249. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Oliveira C, Seruca R and Carneiro F:
Hereditary gastric cancer. Best Prac Res Clin Gastroenterol.
23:147–157. 2009. View Article : Google Scholar
|
|
10.
|
González CA, Sala N and Capellá G: Genetic
susceptibility and gastric cancer risk. Int J Cancer. 100:249–260.
2002.
|
|
11.
|
Perera FP and Weinstein IB: Molecular
epidemiology: recent advances and future directions.
Carcinogenesis. 21:517–524. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ames BN: Cancer prevention and diet: help
from single nucleotide polymorphisms. Proc Natl Acad Sci USA.
96:12216–12218. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
McMahon G: VEGF receptor signaling in
tumor angiogenesis. Oncologist. 5(Suppl 1): 3–10. 2000. View Article : Google Scholar
|
|
14.
|
Gaur P, Bose D, Samuel S and Ellis LM:
Targeting tumor angiogenesis. Semin Oncol. 36(Suppl 1): 12–19.
2009. View Article : Google Scholar
|
|
15.
|
Ferrara N: VEGF and the quest for tumour
angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Vincenti V, Cassano C, Rocchi M and
Persico G: Assignment of the vascular endothelial growth factor
gene to human chromosome 6p21.3. Circulation. 93:1493–1495. 1996.
View Article : Google Scholar
|
|
17.
|
Otrock ZK, Makarem JA and Shamseddine AI:
Vascular endothelial growth factor family of ligands and receptors:
review. Blood Cells Mol Dis. 38:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Zhang Z, Neiva KG, Lingen MW, et al:
VEGF-dependent tumor angiogenesis requires inverse and reciprocal
regulation of VEGFR1 and VEGFR2. Cell Death Differ. 17:499–512.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Ichikura T, Tomimatsu S, Ohkura E, et al:
Prognostic significance of the expression of vascular endothelial
growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol.
78:132–137. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Lieto E, Ferraraccio F, Orditura M, et al:
Expression of vascular endothelial growth factor (VEGF) and
epidermal growth factor receptor (EGFR) is an independent
prognostic indicator of worse outcome in gastric cancer patients.
Ann Surg Oncol. 15:69–79. 2008. View Article : Google Scholar
|
|
21.
|
Smith MG, Hold GL, Tahara E, et al:
Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006.
|
|
22.
|
Watson CJ, Webb NJ, Bottomley MJ, et al:
Identification of polymorphisms within the vascular endothelial
growth factor (VEGF) gene: correlation with variation in VEGF
protein production. Cytokine. 12:1232–1235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Vandenbroucke JP, von Elm E, Altman DG, et
al: Strengthening the reporting of observational studies in
epidemiology (STROBE): explanation and elaboration. Epidemiology.
18:805–835. 2007. View Article : Google Scholar
|
|
24.
|
Zintzaras E and Ioannidis JP:
Heterogeneity testing in meta-analysis of genome searches. Genet
Epidemiol. 28:123–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1158. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Viechtbauer W: Confidence intervals for
the amount of heterogeneity in meta-analysis. Stat Med. 26:37–52.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Peters JL, Sutton AJ, Jones DR, et al:
Comparison of two methods to detect publication bias in
meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Tzanakis N, Gazouli M, Rallis G, et al:
Vascular endothelial growth factor polymorphisms in gastric cancer
development, prognosis, and survival. J Surg Oncol. 94:624–630.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Chae YS, Kim JG, Sohn SK, et al:
Investigation of vascular endothelial growth factor gene
polymorphisms and its association with clinicopathologic
characteristics in gastric cancer. Oncology. 71:266–272. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Bae SJ, Ahn DH, Hong SP, et al:
Gender-specific association between polymorphism of vascular
endothelial growth factor (VEGF 936C>T) gene and patients with
stomach cancer. Yonsei Med J. 49:783–791. 2008.
|
|
31.
|
Ke Q, Liang J, Wang LN, et al: Potentially
functional polymorphisms of the vascular endothelial growth factor
gene and risk of gastric cancer. Mol Carcinog. 47:647–651. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Al-Moundhri MS, Al-Nabhani M, Burney IA,
et al: Gastric cancer risk predisposition and prognostic
significance of vascular endothelial growth factor (VEGF) gene
polymorphisms: a case-control study in an Omani population. Mol
Carcinog. 48:1170–1176. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Guan X, Zhao H, Niu J, et al: The VEGF
-634G>C promoter polymorphism is associated with risk of gastric
cancer. BMC Gastroenterol. 9:772009.
|
|
34.
|
Tahara T, Shibata T, Nakamura M, et al:
Effect of polymorphisms in the 3′ untranslated region (3′-UTR) of
vascular endothelial growth factor gene on gastric cancer and
peptic ulcer diseases in Japan. Mol Carcinog. 48:1030–1037.
2009.
|
|
35.
|
Xia HZ, Wu Q, Liu Y, et al: Association
ofVEGF rs3025039 and rs3025021 with VEGF and COX-2 expression in
gastric cancer tissues. J Clin Exp Pathol. 26:139–143. 2010.
|
|
36.
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Uthoff SM, Duchrow M, Schmidt MH, et al:
VEGF isoforms and mutations in human colorectal cancer. Int J
Cancer. 101:32–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Yuan A, Yu CJ, Chen WJ, et al: Correlation
of total VEGF mRNA and protein expression with histologic type,
tumor angiogenesis, patient survival and timing of relapse in
non-small-cell lung cancer. Int J Cancer. 89:475–483. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Krippl P, Langsenlehner U, Renner W, et
al: A common 936 C/T gene polymorphism of vascular endothelial
growth factor is associated with decreased breast cancer risk. Int
J Cancer. 106:468–471. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Lin CC, Wu HC, Tsai FJ, et al: Vascular
endothelial growth factor gene -460 C/T polymorphism is a biomarker
for prostate cancer. Urology. 62:374–377. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Taylor JG, Choi EH, Foster CB, et al:
Using genetic variation to study human disease. Trends Mol Med.
7:507–512. 2001. View Article : Google Scholar : PubMed/NCBI
|
